SIGLEC1 and neoplasm: CD169 is an adhesion molecule that plays context-dependent roles; it is a macrophage marker distinct from protypical M1/M2 markers, with tumor-associated macrophage immunomodulatory properties (Saito et al, 2015; Fraschilla & Pillai, 2017; Kawaguchi et al, 2022).